NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘Forbion Capital Partners’

24 March 2015

New VCs help anti-cancer treatment pioneer Rigontec push Series A to €14.25m

Dutch early stage investor Forbion Capital Partners and Danish peer Sunstone Capital have brought biopharma business Rigontec's Series A round to €14.25m through a second close.

5 August 2014

Forbion exits 2006 investment in Santaris to Roche for up to €450m

santaris Dutch early stage investment firm Forbion Capital Partners has sold Danish biopharmaceutical company Santaris Pharma to Roche in a deal worth up to $450m.

7 February 2014

Gene therapy company uniQure raises over $80m via IPO

biotech_lrg Venture capital-backed gene therapy specialist uniQure has raised nearly $82m via an IPO on the Nasdaq exchange, which was priced above the indicative range.

3 January 2014

Gene therapy company uniQure plans $75m Nasdaq IPO

stocks2_lrg Venture capital-backed gene therapy specialist uniQure plans to raise $75m via an IPO on the Nasdaq exchange, according to a filing with US securities regulators.

15 October 2012

Biotech company Promedior seals $24.5m Series D

Clinical stage biotechnology company Promedior has completed a $24.5m Series D financing round, adding $3m from corporate venture capital firm Shire Strategic Investment Group.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015